IDEAYA Biosciences (IDYA) Revenue (2020 - 2026)

IDEAYA Biosciences (IDYA) has 7 years of Revenue data on file, last reported at $6.6 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue changed N/A year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $232.3 million (changed N/A YoY), and the FY2025 full-year result was $218.7 million, up 3024.43% from the prior year.
• Revenue eased to $6.6 million in Q1 2026, from $10.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $207.8 million in Q3 2025 to a low of $3.5 million in Q2 2023.
• A 5-year average of $25.5 million and a median of $7.4 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue soared 230.87% in 2022 and slumped 72.94% in 2023, its largest moves.
• Tracing IDYA's Revenue over 5 years: stood at $4.0 million in 2022, then slipped by 2.49% to $3.9 million in 2023, then jumped by 78.48% to $7.0 million in 2024, then surged by 55.37% to $10.9 million in 2025, then tumbled by 39.68% to $6.6 million in 2026.
• Business Quant data shows IDYA's Revenue at $6.6 million in Q1 2026, $10.9 million in Q4 2025, and $207.8 million in Q3 2025.